Results 101 to 110 of about 8,597,475 (170)

Intravitreal aflibercept versus intravitreal ranibizumab for the treatment of diabetic macular edema

, 2017
Sameh Mosaad Fouda, Ahmed M Bahgat Department of Ophthalmology, Faculty of Medicine, Zagazig University, Zagazig, Egypt Purpose: The purpose of this study was to compare the efficacy of intravitreal aflibercept and ranibizumab in the treatment of ...
Bahgat AM, Fouda SM
core  

Measurement of Acute Intraocular Pressure Elevation Immediately After Intravitreal Anti-VEGF Injection and Analysis of Prefilled Syringe Accuracy

Clinical Ophthalmology
Kaku Itoh, Misaki Negishi Departments of Ophthalmology, Muroran City General Hospital, Muroran City, Hokkaido, JapanCorrespondence: Kaku Itoh, Departments of Ophthalmology, Muroran City General Hospital, 3-8-1 Yamate-cho, Muroran City, Hokkaido, Japan ...
Itoh K, Negishi M
doaj  

Intravitreal aflibercept for choroidal neovascularization associated with chorioretinitis: a pilot study

, 2017
Andrii R Korol,1 Oleksandra Zborovska,2 Taras Kustryn,1 Oleksandra Dorokhova,2 Nataliya Pasyechnikova3 1Laser Department, 2Department of Inflammatory Pathology of the Eye, 3Filatov Institute of Eye Diseases and Tissue Therapy, National Academy
Kustryn T, Korol AR, Zborovska O, Dorokhova O, Pasyechnikova N   +4 more
core  

Visual Gains with Faricimab vs Aflibercept 8 mg in Naïve Retinovascular Disease: Global Real-World Cases and Literature Review. [PDF]

Clin Ophthalmol
Mansour HA, Eandi CM, Pichi F, Foster RE, Charbaji SA, Chakraborty D, Ellabban AA, Belotto S, Abu Serhan H, Magnin S, Lopez-Guajardo L, Pérez-Salvador García E, Schwartz SG, Stewart MW, Rey A, Jürgens I, Casella AMB, Upadhyay A, Sheth JU, Lima LH, Sinawat S, Abengoechea S, Capella MJ, Viver Oller S, Elizalde J, Kheir WJ, Mammo D, Barbosa GCS, Villegas VM, Desai A, Tripathy K, Bala S, Mohan N, Elnahry AG, Uwaydat SH, Cherfan DG, Parodi MB, Mansour AM.   +37 more
europepmc   +1 more source

OCCLUSIVE RETINAL VASCULITIS AFTER AFLIBERCEPT 8 mg INJECTION FOR WET MACULAR DEGENERATION. [PDF]

Retin Cases Brief Rep
Sisk RA.
europepmc   +1 more source

Effect of intravitreal aflibercept on corneal endothelial cells: a 6-month follow-up study

, 2019
Tetsuya Muto, Shigeki Machida Department of Ophthalmology, Dokkyo Medical University Saitama Medical Center, Koshigaya, Japan Purpose: To determine the effect of intravitreal aflibercept injection on the corneal endothelium in patients with diabetic or
Muto T, Machida S
core  

Intravitreal aflibercept for choroidal neovascularization secondary to angioid streaks in a non-responder to intravitreal ranibizumab

, 2018
Olga E Makri, Foteini N Tsapardoni, Panagiotis Plotas, Athina Pallikari, Constantine D Georgakopoulos Department of Ophthalmology, University of Patras, Patras, Greece Purpose: To report the 12-month outcomes of a patient switching from intravitreal ...
Tsapardoni FN, Georgakopoulos CD, Plotas P, Makri OE, Pallikari A   +4 more
core  

Comparison of Choroidal Morphological Changes Between Aflibercept 8 mg and Faricimab-svoa in Treatment-Naïve Polypoidal Choroidal Vasculopathy and Pachychoroid Neovasculopathy. [PDF]

J Clin Med
Jeong S, Seong SH, Sagong M.
europepmc   +1 more source

Lower Rates of Intraocular Inflammation with Aflibercept 8 mg Delivered via Pre-Filled Syringe Versus Vial. [PDF]

Ophthalmol Ther
Hoffmann L, Hatz K.
europepmc   +1 more source

Early intraocular pressure dynamics after intravitreal aflibercept 8 mg versus 2 mg

Scientific Reports
Jung-Tae Kim, Ji-Ho Jun, Han-Jun Chung, Min-Woo Lee   +3 more
openaire   +1 more source